Tumor Tissue Shared Resource - Published Research

Citation Reference Language for Use of Shared Resource

“The Tumor Tissue and Pathology Shared Resource services are supported by the Comprehensive Cancer Center of Wake Forest Baptist Medical Center NCI CCSG P30CA012197 grant.”

Publications

Program Key: CPC = Cancer Prevention and Control Program; CRP = Clinical Research Program; TPR = Tumor Progression and Recurrence Program; CBB = Cancer Biology and Biochemistry Program

1. Maglic D, Zhu S, Fry EA, Taneja P, Kai F, Kendig RD, Sugiyama T, Miller LD(TPR), Willingham MC(TPR), Inoue K.  Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer. Oncogene. 2013;32(35): 4120-9 PMC3742602.

2.  Xing F, Sharma S, Liu Y, Mo YY, Wu K, Zhang YY, Pochampally R, Martinez LA, Lo HW(TPR), Watabe K(TPR).  miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-alpha. Oncogene. 2015;34: 4890-900 PMC4530094.

3. Maglic D, Stovall DB, Cline M(TPR), Fry EA, Mallakin A, Taneja P, Caudell DL, Willingham MC, Sui G(TPR), Inoue K.  DMP1beta, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer. J Pathol. 2015;236(1): 90-102 PMC4398631.

4. Stovall DB, Wan M, Miller LD(TPR), Cao P, Maglic D, Zhang Q, Stampfer MR, Liu W(CPC), Xu J(CPC), Sui G(TPR).  The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol. 2013;183(5): 1645-53 PMC3814686.

5. Pardee TS(CRP), Lee K, Luddy J, Maturo C, Rodriguez RJ, Isom S, Miller LD(TPR), Ellis LR, Levitan D, Hurd D(CRP), Powell BL(CRP), et al.  A phase I study of the first-in-class anti-mitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies. Clin Cancer Res. 2014;20(20): 5255-64 PMC4199870.

6. Pardee TS(CRP), Stadelman K, Jennings-Gee J, Caudell DL, Gmeiner WH(CBB).  The poison oligonucleotide F10 is highly effective against acute lymphoblastic leukemia while sparing normal hematopoietic cells. Oncotarget. 2014;5: 4170-9 PMC4147314.

7. Levine EA(CRP), Blazer DG, Kim MK, Shen P(CRP), Stewart JH(CRP), Guy C, Hsu DS.  Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J Am Coll Surg. 2012;214(4): 599-606 PMC3768122.

8. Cook GJ, Caudell DL, Elford HL, Pardee TS(CRP).  The efficacy of the ribonucleotide reductase inhibitor didox in preclinical models of AML. Plos One. 2014;9(11): e112619 PMC4234372.

 

9. Ding S, Qiao X, Suryadi J, Marrs GS, Kucera GL(CBB), Bierbach U(CBB).  Using fluorescent post-labeling to probe the subcellular localization of DNA-targeted platinum anticancer agents. Angew Chem Int Ed Engl. 2013;52(12): 3350-4 PMC3852910.

10. Bansal N, Mims J, Kuremsky JG, Olex AL, Zhao W, Yin L, Wani R, Qian J, Tsang AW(TPR), Porosnicu M(CRP), Furdui C(CBB), et al.  Broad phenotypic changes associated with gain of radiation resistance in HNSCC. Antioxid Redox Signal. 2014;21: 221-36 PMC4060837.

11. Ding S, Qiao X, Kucera GL(CBB), Bierbach U(CBB).  Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer. Chem Commun (Camb). 2013;49(24): 2415-7 PMC3606895.

12. Graham LA, Suryadi J, West TK, Kucera GL(CBB), Bierbach U(CBB).  Synthesis, aqueous reactivity, and biological evaluation of carboxylic Acid ester-functionalized platinum-acridine hybrid anticancer agents. J Med Chem. 2012;55(17): 7817-27 PMC3478695.

    Quick Reference

    Tumor Tissue Shared Resource
    Tiffany Walker West
    Tumor Tissue Lab

    336-716-3721

    twalkerw@wakehealth.edu

    Libby Williams
    Tumor Tissue Lab

    336-716-5355

    lmcwilli@wakehealth.edu

    Greg Kucera, PhD
    Tumor Tissue Lab

    336-716-6348

    gkucera@wakehealth.edu

    Tammy Sexton
    Human Pathology Lab

    336-716-6012

    tsexton@wakehealth.edu

    Shadi Qasem, MD
    Human Pathology Lab

    336-716-2640

    sqasem@wakehealth.edu

    Lisa O'Donnell
    Comparative Pathology Lab

    336-716-1549

    lodonnel@wakehealth.edu

    David Caudell, DVM, PhD
    Comparative Pathology Lab

    336-716-4763

    dcaudell@wakehealth.edu

    Find A Doctor Ways to Give
    Last Updated: 05-12-2016
    Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

    Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

    © Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.